-
admin
Posts
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas
Patients dosed in Phase 1 safety and tolerability study of MDX2003, a novel T-cell engager designed to optimize killing of lymphomas Preclinical studies presented at...
Banyan Group Releases 2025 Sustainability Report, Marking 20 Years of Reporting and 100-Property Milestone
Report sets out the Group’s next chapter, with its first double materiality assessment, three new Impact Pathways, and a commitment to scaling sustainability with the...
Meet V2700 — The World’s First RPU-Powered Wi-Fi Router
One Router. No Mesh. No Dead Zones. — V2700 is the industry‘s first router to fix Wi-Fi at the signal level. NEW YORK, April 22, 2026 /PRNewswire/...
Yalla Group Limited Files 2025 Annual Report on Form 20-F
DUBAI, UAE, April 22, 2026 /PRNewswire/ — Yalla Group Limited (“Yalla” or the “Company”) (NYSE: YALA), the largest Middle East and North Africa (MENA)-based online...
Shinhan Financial Group files its FY2025 Form 20-F to the SEC
SEOUL, South Korea, April 22, 2026 /PRNewswire/ — Shinhan Financial Group (NYSE: SHG) (KRX: 055550) filed its Annual Report on Form 20-F for the year ended...
Gensyn Launches Delphi, the AI-Powered Information Market Reshaping the $250 Billion Creator Economy
Delphi breaks centralised control from traditional prediction market models, turning creators into market owners and audiences into information traders LONDON, April 22, 2026 /PRNewswire/ —...
ROSEN, A LEADING LAW FIRM, Encourages Coty Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – COTY
NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Coty...
REMINDER: Coty Inc. Investors With Significant Losses Must Act By May 22, 2026 – Contact Kirby McInerney LLP
NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) — Kirby McInerney LLP reminds Coty Inc. (“Coty” or the “Company”) (NYSE:COTY) investors of the May 22, 2026...
Curiox Biosystems Signs Master Software License Agreement for Enterprise-Scale Pluto Code Deployment
First master licensing framework for Pluto Code enables a global pharmaceutical organization to expand centrifuge-free automation across its liquid-handling infrastructure without repeated contracting WOBURN, Mass.,...
Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026
ROCKVILLE, Md. and SUZHOU, China, April 21, 2026 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical...
